Construction of Early Warning Model for the New Psychoactive Substances Using in Adolescents

Launched by WEI XIA, PHD · Jul 21, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on developing a new model to identify adolescents who may be at risk of using New Psychoactive Substances (NPS), which are drugs that can affect the brain and behavior. Researchers want to understand how factors like genetics, childhood experiences, and thinking patterns relate to the likelihood of substance use among young people aged 14 to 35. They plan to gather information through questionnaires from about 200 participants to help create this early warning model using advanced data analysis techniques.

To be eligible for this study, participants need to be between 14 and 35 years old and willing to take part. However, individuals with a history of mental health issues, those who are not able to communicate effectively, or those with severe health conditions will not be able to join. If selected, participants will complete surveys that ask about their experiences and behaviors related to drug use. This research could ultimately help in identifying at-risk youth and potentially guide future prevention strategies.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adolescents aged 14-35 (including 14,35 years old)
• • Agree to participate in the studies
• Exclusion Criteria:
• • Be diagnosed with psychological or mental illness
• • People that are unconscious, emotionally unstable, or unable to communicate normally
• • Patients with severe diseases